drugset / Trial / NCT00003426

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

NCT00003426 ↗

Treatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of gemcitabine plus radiation therapy in treating patients with pancreatic cancer that can not be surgically removed.

Timeline

Start
1998-04
Primary completion
2002-03
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — Intravenous